Gainers
- Virpax Pharmaceuticals (NASDAQ:VRPX) stock moved upwards by 9.6% to $1.0 during Friday's after-market session. The market value of their outstanding shares is at $11.6 million.
- Nuwellis (NASDAQ:NUWE) shares rose 8.77% to $2.48. The market value of their outstanding shares is at $2.9 million.
- NanoVibronix (NASDAQ:NAOV) shares rose 8.35% to $3.5. The company's market cap stands at $5.8 million.
- Greenwich LifeSciences (NASDAQ:GLSI) stock rose 6.84% to $9.72. The market value of their outstanding shares is at $124.9 million.
- Becton, Dickinson (NYSE:BDX) shares increased by 6.63% to $282.4. Today's trading volume for this security ended up closing at 72.5K shares, which is 6.5 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $80.2 billion.
- Ra Medical Systems (AMEX:RMED) shares increased by 6.5% to $0.72. The company's market cap stands at $4.6 million.
Losers
- ALX Oncology Holdings (NASDAQ:ALXO) stock fell 12.3% to $5.9 during Friday's after-market session. The market value of their outstanding shares is at $241.1 million.
- ViewRay (NASDAQ:VRAY) stock fell 11.02% to $0.05. Today's trading volume for this security ended up closing at 6.8 million shares, which is 65.6 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $9.6 million.
- Verrica Pharmaceuticals (NASDAQ:VRCA) shares decreased by 10.8% to $6.65. At the close, Verrica Pharmaceuticals's trading volume reached 285.6K shares. This is 120.4% of its average volume over the last 100 days. The company's market cap stands at $278.3 million.
- Biophytis (NASDAQ:BPTS) shares declined by 8.74% to $2.09. The company's market cap stands at $6.5 million.
- InspireMD (NASDAQ:NSPR) shares fell 8.54% to $3.0. The market value of their outstanding shares is at $63.5 million.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) shares fell 8.4% to $5.13. The market value of their outstanding shares is at $1.2 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
